Qualitative and Quantitative Assessment of the Benefit-Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In Vivo : Characterisation of Drugs with an Increased Benefit-Risk Ratio

Author： Schackert C.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.13, Iss.4, 2000-04, pp. : 267-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Séparation des énantiomères : pour quelle amélioration du rapport bénéfice/risque ?: Chiral Switch: Towards a Better Benefit-Risk Ratio?

By Blin Olivier  

Therapie, Vol. 59, Iss. 6, 2004-01 ,pp. : 625-628

Adis International

Access to resources Recommend Favorite

Risk-Benefit Assessment of Methotrexate in the Treatment of Severe Psoriasis

By Kuijpers A.L.   van der Kerkhof P.C.M.  

American Journal of Clinical Dermatology, Vol. 1, Iss. 1, 2000-01 ,pp. : 27-39

Adis International

Access to resources Recommend Favorite

Editorial [ Risk Benefit: Who is Responsible? ]

By  

Current Drug Therapy, Vol. 2, Iss. 1, 2007-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Vulnerability, Risk, and Qualitative Methodologies

By Angus Jan E.  

CJNR (Canadian Journal of Nursing Research), Vol. 45, Iss. 3, 2013-0 ,pp. : 3-5

McGill School of Nursing

Access to resources Recommend Favorite

Pre-admission nursing assessment in a Welsh Medium Secure Unit (1991-2000): Part 2-comparison of traditional nursing assessment with the HCR-20 risk assessment tool

By Watt A.   Topping-Morris B.   Rogers P.   Doyle M.   Mason T.  

International Journal of Nursing Studies, Vol. 40, Iss. 6, 2003-08 ,pp. : 657-662

Elsevier

Access to resources Recommend Favorite